井寺制药(IDRA)

琳子的日复一日2018-04-13 19:51

$井寺制药(IDRA)$ Idera Pharmaceuticals (IDRA) launched a phase 3 trial in patients with anti-PD-1 refractory melanoma. Patients will be treated in combination with Idera's IMO-2125 and Bristol-Myers Squibb (BMY) Yervoy (Ipilimumab) against Yervoy alone. The phase 3 study ...查看全文

WitnessBio2018-04-12 11:39

$井寺制药(IDRA)$ 今天进了一些仓位。IDRA将会在六月一号到五号的ASCO年会上发布IMO-2125的最新临床数据。它和BCRX将在七月十号开一个特别会议商讨两家合并的事宜。贝壳兄弟今年一月加仓了超过20M股，现在一共拥有将近39M股。查看全文

薛定锷之猫2017-10-31 10:08

$井寺制药(IDRA)$ 贝壳兄弟持有16.5m股，其中8m是现金1.5左右买入。查看全文

Rex-二哥2017-10-25 12:37

$井寺制药(IDRA)$ 这股等增股合股结束还是可以买的，明年一月后考虑查看全文

美股异动2017-04-12 09:39

【昨日盘前异动 - 详情】
SALE： 涨49% to be acquired by Harland Clarke Holdings for $11.60 per share in cash.
TNXP： 涨30% on reporting results from U.S. FDA initial cross-disciplinary breakthrough meeting on TNX-102 SL for posttraumatic stress disorder.
CBIO： 涨1...查看全文

薛定锷之猫2017-03-28 05:34

$井寺制药(IDRA)$ 贝克兄弟买那么多股为啥？查看全文

资本主义拉美行不通2016-10-20 22:09

$井寺制药(IDRA)$我的天，竟然还有我卖飞的股票查看全文

资本主义拉美行不通2016-10-12 12:07

$井寺制药(IDRA)$ 这股有它得价值，建仓有点早，盘后涨这么多还是没有到成本线，继续持有查看全文

菜菜小白2016-10-07 23:21

$井寺制药(IDRA)$一夜回到解放前。昨天心急进了，没想到跌这么多。增发股票就是毒药啊。。查看全文

美东时间 2011-08-11 21:30 Q2 2011 Idera Pharmaceuticals Inc Earnings Release

美东时间 2011-06-29 22:30 Idera Pharmaceuticals Inc at Biotechnology Industry Organization International Convention

当期报告

$井寺制药(IDRA)$ 8-K Current report, items 5.03, 7.01, 8.01, and 9.01 Accession Number: 0001104659-23-004326  Act: 34  Size: 780 KB 网页链接

当期报告

$井寺制药(IDRA)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001104659-23-003629  Act: 34  Size: 375 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000919  Size: 4 KB 网页链接

当期报告

$井寺制药(IDRA)$ 8-K Current report, item 8.01 Accession Number: 0001104659-23-002936  Act: 34  Size: 199 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000764  Size: 6 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000765  Size: 6 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000766  Size: 6 KB 网页链接

员工持股计划

$井寺制药(IDRA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-22-129602  Act: 33  Size: 154 KB 网页链接

当期报告「修正」

$井寺制药(IDRA)$ 8-K/A [Amend] Current report, items 8.01 and 9.01 Accession Number: 0001104659-22-125903  Act: 34  Size: 228 KB 网页链接

股东委托书协议

$井寺制药(IDRA)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-22-125528  Act: 34  Size: 5 MB 网页链接